| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8276432 | Journal of the Neurological Sciences | 2015 | 10 Pages |
Abstract
Results indicate robust improvement in clinical ratings and excellent tolerability following onabotulinumtoxinA treatment of CD.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Joseph Jankovic, Charles H. Adler, David Charles, Cynthia Comella, Mark Stacy, Marc Schwartz, Aubrey Manack Adams, Mitchell F. Brin,